USQuality shares for uncertain timesDan Jones explains what an American quality share should look like in an era when AI dominates the S&P 5004 December 2025
USShares in this Buffett favourite are definitely investment gradeIt faces threats, but there are reasons why the Sage of Omaha has owned this stock for 25 years 4 December 2025
USA deal with Donald Trump is boosting this pharma giant Its weight-loss drugs are more accessible, and it has secured tariff exemptions4 December 2025
USThis reliable compounder is turning rags into richesInvestors will need deep pockets to take a stake in this prodigious compounder, but it’s worth it4 December 2025
USA payments business outgrowing its pastIts shares are down due to macro worries, but the company is quickly moving to a less cyclical model4 December 2025